Abstract:<p>Epilepsy is accompanied by abnormal neurotransmission, and microRNAs, as versatile players in the modulation of gene expression, are important in epilepsy pathology. Here, we found that miR-128 expression was elevated in the acute seizure phase and decreased during the recurrent seizure phase after status epilepticus in mice. Both SNAP-25 and SYT1 are regulated by miR-128 in vitro and in vivo. Overexpressing miR-128 in cultured neurons decreased neurotransmitter released by suppressing SNAP-25 and SYT1 expression. Anti-miR-128 injection before kainic acid (KA) injection increased the sensitivity of mice to KA-induced seizures, while overexpressing miR-128 at the latent and recurrent phases had a neuroprotective effect in KA-induced seizures. Our study shows for the first time that miR-128, a key regulator of neurotransmission, plays an important role in epilepsy pathology and that miR-128 might be a potential candidate molecular target for epilepsy therapy.</p>

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of miR - 128 in the pathology of epilepsy and its mechanism. Specifically, the researchers focused on how miR - 128 regulates neurotransmission in the hippocampus by inhibiting the expression of presynaptic proteins SNAP - 25 and SYT1, thereby affecting the sensitivity to epilepsy. The study found that in the kainic acid (KA) - induced mouse epilepsy model, the expression of miR - 128 increased during the acute seizure phase, while it decreased during the latent and recurrence phases. By down - regulating or over - expressing miR - 128, the sensitivity of mice to KA - induced epilepsy can be increased or decreased respectively, indicating that miR - 128 may become a potential molecular target for the treatment of epilepsy. The key points of the paper include: 1. **Changes in miR - 128 expression**: The study found that the expression of miR - 128 increased during the acute seizure phase and decreased during the latent and recurrence phases. 2. **SNAP - 25 and SYT1 as targets of miR - 128**: Through bioinformatics analysis and luciferase reporter gene experiments, SNAP - 25 and SYT1 were verified as targets of miR - 128. 3. **The impact of miR - 128 on neurotransmission**: Over - expressing miR - 128 in cultured neurons can reduce the protein levels of SNAP - 25 and SYT1, thereby reducing the release of neurotransmitters. 4. **The role of miR - 128 in the epilepsy model**: By stereotactic injection of anti - sense molecules or over - expression vectors of miR - 128, the study found that down - regulating miR - 128 would increase the sensitivity of mice to KA - induced epilepsy, while over - expressing miR - 128 has an anti - epilepsy effect. These findings not only reveal the important role of miR - 128 in the pathogenesis of epilepsy, but also provide potential molecular targets for the development of new anti - epilepsy therapies.

miR-128 regulates epilepsy sensitivity in mice by suppressing SNAP-25 and SYT1 expression in the hippocampus